ZA882880B - - Google Patents

Info

Publication number
ZA882880B
ZA882880B ZA882880A ZA882880A ZA882880B ZA 882880 B ZA882880 B ZA 882880B ZA 882880 A ZA882880 A ZA 882880A ZA 882880 A ZA882880 A ZA 882880A ZA 882880 B ZA882880 B ZA 882880B
Authority
ZA
South Africa
Prior art keywords
cephem
derivatives
carbocyclic
conjugated
alkenyl
Prior art date
Application number
ZA882880A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ZA882880B publication Critical patent/ZA882880B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
ZA882880A 1987-02-26 1988-04-22 ZA882880B (ja)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US07/019,395 US4847373A (en) 1987-02-26 1987-02-26 Production of 3-allyl- and 3-butenyl-3-cephems
US07/019,396 US4870168A (en) 1987-02-26 1987-02-26 3-Unsaturated alkyl cephems from 3-triflyl cephems
IE117988A IE64885B1 (en) 1987-02-26 1988-04-19 A process for the production of 3-hydrocarbyl-3-cephems
AU14758/88A AU602395B2 (en) 1987-02-26 1988-04-19 3-unsaturated alkyl cephems from 3-triflyl cephems
FI881872A FI91760C (fi) 1987-02-26 1988-04-21 Menetelmä terapeuttisesti käyttökelpoisten 7-substituoitujen asetamido-3-alkenyyli-3-kefeemijohdannaisten valmistamiseksi
FI881904A FI94253C (fi) 1987-02-26 1988-04-22 Menetelmä 3-kefeemijohdannaisten valmistamiseksi
HU882083A HU207521B (en) 1987-02-26 1988-04-25 Process for producing 3-substituted 3-cepheme-derivatives
CS882885A CS272234B2 (en) 1987-02-26 1988-04-28 Method of 3-hydrocarbyl-3-cephaem derivative production
PT87367A PT87367B (pt) 1987-02-26 1988-04-29 Processo para a preparacao de derivados de alquil-cefem insaturados em posicao 3 a partir de novos compostos intermedios derivados de 3-triflil-cefem
CA000564614A CA1338644C (en) 1987-02-26 1988-05-18 Production of 3-allyl- and 3-butenyl-3-cephems
CN88102961A CN1035181C (zh) 1987-02-26 1988-05-20 从3－三氟甲磺酰氧基头孢烯制备3－不饱和烃基头孢烯的方法
JP63130057A JP2650716B2 (ja) 1987-02-26 1988-05-27 ３−アリル及び３−ブテニル−３−セフェムの製造
EP88108505A EP0343277B1 (en) 1987-02-26 1988-05-27 A process for the production of 3-hydrocarbyl-3-cephems
JP63134270A JP2706090B2 (ja) 1987-02-26 1988-05-31 ３−トリフリルセフェムからの３−不飽和アルキルセフェム
DD88327653A DD280533A5 (de) 1987-02-26 1988-06-07 Verfahren zur herstellung von 3-trifluormethan-sulfonyloxy-3-cephem-zwischenverbindungen
DD88316493A DD270712A5 (de) 1987-02-26 1988-06-07 Verfahren zur herstellung von (hydrocarbyl)-3-cephem-derivaten

Publications (1)

Publication Number Publication Date
ZA882880B true ZA882880B (ja) 1988-10-27

Family

ID=39688793

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882880A ZA882880B (ja) 1987-02-26 1988-04-22

Country Status (16)

Country Link
US (2) US4870168A (ja)
EP (2) EP0342252A1 (ja)
JP (2) JP2650716B2 (ja)
CN (1) CN1035181C (ja)
AT (1) ATE112571T1 (ja)
AU (2) AU602395B2 (ja)
CA (1) CA1338644C (ja)
CS (1) CS272234B2 (ja)
DD (2) DD270712A5 (ja)
DE (1) DE3851749T2 (ja)
ES (1) ES2060619T3 (ja)
FI (2) FI91760C (ja)
HU (1) HU207521B (ja)
IE (1) IE64885B1 (ja)
PT (1) PT87367B (ja)
ZA (1) ZA882880B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
US5245027A (en) * 1989-11-21 1993-09-14 Bristol-Myers Squibb Company 3-fluorosulfonyloxyceph-3-em compounds
US5043439A (en) * 1990-03-08 1991-08-27 Bristol-Myers Squibb Company Process for production of cephalosporins
DE4030706A1 (de) * 1990-09-28 1992-04-02 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5106842A (en) * 1990-10-22 1992-04-21 Bristol-Myers Squibb Co. Antibiotic c-3 cyclobutenedione substituted (1-carba)cephalosporin compounds, compositions, and methods of use thereof
DE4037841A1 (de) * 1990-11-28 1992-06-04 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AT396106B (de) * 1991-03-08 1993-06-25 Biochemie Gmbh Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
KR950700311A (ko) * 1992-02-05 1995-01-16 게오르게스 그렐리니, 한스 루돌프하우스 3-세펨-4-카복실산 유도체의 정제방법(Process for the purification of a 3-cephem-4-carboxylic acid derivatives)
JP3224279B2 (ja) * 1992-07-27 2001-10-29 大塚化学株式会社 セフエム化合物の製造法
US5789584A (en) * 1994-04-01 1998-08-04 Microcide Pharmaceuticals, Inc. Substituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteria
US5698547A (en) * 1994-04-01 1997-12-16 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US5688786A (en) * 1994-04-01 1997-11-18 Microcide Pharmaceuticals, Inc. β-lactam antibiotics
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
JP4535530B2 (ja) * 1999-09-20 2010-09-01 大塚化学株式会社 ３−スルホニルオキシ−３−セフェム化合物の製造方法
TW500724B (en) 1999-10-05 2002-09-01 Pharmacia & Amp Upjohn Company Oxazinoquinolones useful for the treatment of viral infections
US6821969B2 (en) * 2001-02-13 2004-11-23 Pharmacia & Upjohn Company Thioxazinoquinolones as antiviral agents
EP1458728A1 (en) * 2001-12-13 2004-09-22 Ranbaxy Laboratories Limited Crystalline cefdinir potassium dihydrate
JP2008526782A (ja) * 2005-10-31 2008-07-24 テバ ファーマシューティカル インダストリーズ リミティド セフジニルセシウム塩結晶
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
CA2935651A1 (en) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Broad spectrum beta-lactamase inhibitors
ES2700575T3 (es) 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
US3959324A (en) * 1972-04-26 1976-05-25 The Procter & Gamble Company Alkyltin cyclopropylcarbinylsulfonate
GB1377624A (en) * 1972-07-07 1974-12-18 Glaxo Lab Ltd Cephalosporin compounds
JPS543087A (en) * 1977-06-03 1979-01-11 Fujisawa Pharmaceut Co Ltd Preparation of cephalosporin compound
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
JPS5758689A (en) * 1980-09-25 1982-04-08 Toyama Chem Co Ltd Novel preparation of 7-substituted or unsubstituted amino-3-substituted methylcephem carboxylic acids
US4537886A (en) * 1982-03-31 1985-08-27 Beecham Group P.L.C. β-lactam antibacterial agents and compositions containing them
US4609730A (en) * 1982-11-22 1986-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[substituted imino-2-(2-aminothiazol-4-yl)-acetamido]-3(2,2-dihalovinyl or ethynyl)-3-cephem-4-carboxylic acid (syn isomers), having antimicrobial activities
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
FR2580652B1 (fr) * 1985-04-22 1989-01-06 Bristol Myers Co Acide 7-amino-3-propenylcephalosporanique et ses esters
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4619925A (en) * 1985-11-08 1986-10-28 Bristol-Myers Company 3-Propenyl cephalosporin derivatives
US4727070A (en) * 1985-11-25 1988-02-23 Bristol-Myers Company 3-Propenzl cephalosporin isomer separation process and derivative

Also Published As

Publication number Publication date
FI91760B (fi) 1994-04-29
ATE112571T1 (de) 1994-10-15
FI94253B (fi) 1995-04-28
PT87367A (pt) 1989-11-10
DD280533A5 (de) 1990-07-11
FI881904A (fi) 1989-10-23
AU1651588A (en) 1989-11-23
AU1475888A (en) 1989-10-26
JP2706090B2 (ja) 1998-01-28
HU207521B (en) 1993-04-28
JPH01313483A (ja) 1989-12-18
HUT49885A (en) 1989-11-28
DD270712A5 (de) 1989-08-09
IE64885B1 (en) 1995-09-20
EP0342252A1 (en) 1989-11-23
DE3851749D1 (de) 1994-11-10
FI881904A0 (fi) 1988-04-22
US4847373A (en) 1989-07-11
AU617669B2 (en) 1991-12-05
PT87367B (pt) 1994-04-29
CN1035181C (zh) 1997-06-18
CS272234B2 (en) 1991-01-15
FI91760C (fi) 1994-08-10
ES2060619T3 (es) 1994-12-01
AU602395B2 (en) 1990-10-11
CA1338644C (en) 1996-10-15
US4870168A (en) 1989-09-26
FI881872A (fi) 1989-10-22
CN1037709A (zh) 1989-12-06
JPH01313482A (ja) 1989-12-18
EP0343277B1 (en) 1994-10-05
FI94253C (fi) 1995-08-10
JP2650716B2 (ja) 1997-09-03
FI881872A0 (fi) 1988-04-21
DE3851749T2 (de) 1995-02-09
CS288588A2 (en) 1990-03-14
EP0343277A1 (en) 1989-11-29

Similar Documents

Publication Publication Date Title
ZA882880B (ja)
AU7956291A (en) New salt form
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
HUT34033A (en) Process for preparing penem derivatives
EP0911415A3 (en) Microbiological manufacture of L-ascorbic acid
EP0623622A4 (en) METHOD FOR PRODUCING CEPHEMIC COMPOUNDS.
HUT72040A (en) Process for the manufacture of aminomethanephosphonic acid
EP0617040A3 (en) Production of alkyl phosphites.
ES8507522A1 (es) Un procedimiento para la produccion de un derivado de 2-amino-tiazol.
AU1514092A (en) Improved process for the production of phosphated guar
EP0623623A4 (en) COMPLEX OF 2-AMINETHANESULPHONIC ACID AND ZINC.
TW368503B (en) Process for preparing carbapenem and penem compounds and new compounds involved in that process
PH31046A (en) Chemical process.
FR2664604B1 (fr) Procede de decomposition de complexes d'inclusion de beta-cyclodextrines.
FR2487376B1 (fr) Procede pour la production de polysaccharides par culture d'un bacillus
AR246737A1 (es) Complejos fungicidas imidazolicos
ES2072802A1 (es) Procedimiento para la preparacion de la 7-isopropoxiisoflavona.
GB1503778A (en) Organic diesters and process for the production thereof
GB1368414A (en) 3-phenyl 1-4,5,6-trichloropyridazine and a process for prepa ration thereof
EP0648743A4 (ja)
HUT35656A (en) Process for producing stabile 4,4-dioxy-4-thia-prostacycline derivatives
HU205742B (en) Process for producing alkyl diazoacetates or their solutions